Trials / Completed
CompletedNCT02947139
Drug-Drug Interaction Study Between DWC20155 / DWC20156 and DWC20161 in Healthy Volunteers
A Randomized, Open Label, Crossover Study to Explore Drug-drug Interaction Between DWC20155 / DWC20156 and DWC20161 in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 53 (actual)
- Sponsor
- Daewoong Pharmaceutical Co. LTD. · Industry
- Sex
- All
- Age
- 19 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
A randomized, open label, crossover study to explore drug-drug interactions between DWC20155 / DWC20156 and DWC20161 in Healthy Volunteers
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Co-administration of DWC20155/DWC20156 | |
| DRUG | DWC20161 |
Timeline
- Start date
- 2016-09-29
- Primary completion
- 2016-10-24
- Completion
- 2016-11-02
- First posted
- 2016-10-27
- Last updated
- 2017-02-16
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02947139. Inclusion in this directory is not an endorsement.